Physician Search

Consuelo Wilkins, MD, MSCI, Senior Vice President for Health Equity and Inclusive Excellence for Vanderbilt University Medical Center (VUMC) and Senior Associate Dean for Health Equity and Inclusive Excellence for Vanderbilt University School of Medicine, always knew she wanted to be a physician. "Health equity was built into everything I did, even if I didn’t know it or recognize it at the time," Wilkins said. "I have always learned and believed that people are the same — everyone deserves to be healthy, and everyone should have the best opportunities to take care of themselves and their families." Click below to learn more about health equity initiatives.

https://momentum.vicc.org/2021/09/everyone-deserves-to-be-healthy/

Vanderbilt was the lead site for an NIH-funded, phase 2, multicenter influenza vaccine study in pediatric allogeneic hematopoietic stem cell transplant (HCT) recipients that may lead to a change in the current flu vaccine recommendations in this vulnerable population. Natasha Halasa, MD, MPH and colleagues recently published in the New England Journal of Medicine, that two doses of high-dose trivalent flu vaccine resulted in higher amounts of influenza-specific antibodies than two doses of standard dose quadrivalent vaccine.

https://news.vumc.org/2023/03/02/high-dose-flu-vaccine-beneficial-for-pediatric-stem-cell-transplant-patients/

Filter By:
Search by Keyword:

Displaying 261 - 270 of 299

Biomarker Analysis of Breast Cancer Patients Receiving Immunotherapy

Breast

Disease Sites: Breast

Phase: N/A

Investigator: Balko, Justin

NCTID:

Protocol No: VICCBRE2065

A Natural History Cohort Study of the Safety, Effectiveness, and Practice of Treatment for People with Severe Von Willebrand Disease (VWD)

Hematologic

Disease Sites: Hematologic

Phase: N/A

Investigator: Wheeler, Allison

NCTID:

Protocol No: VICCNCBH19121

Validating an Integrated Biomarker and Imaging Approach in the Evaluation of Indeterminate Pulmonary Nodules.

Lung

Disease Sites: Lung

Phase: N/A

Investigator: Grogan, Eric

NCTID:

Protocol No: VICCTHO2002

Patient and Health Care Provider Perspectives of Naloxone

Miscellaneous

Disease Sites: Miscellaneous

Phase: N/A

Investigator: Hande, Karen

NCTID:

Protocol No: VICCSUPP2068

Pattern of Changes in Immune Profile in the Setting of Chimeric Antigen Receptor T-Cell Therapy

Miscellaneous

Disease Sites: Miscellaneous

Phase: N/A

Investigator: Oluwole, Olalekan

NCTID:

Protocol No: VICCCTT2074

JHMIRB: Prospective Clinical Study of the Relationship Between Cancer Driving Mutations Found in Endometriotic Implants and Development of Progesterone Resistance

Gynecologic

Disease Sites: Gynecologic

Phase: N/A

Investigator: Tran, Kaylon

NCTID:

Protocol No: VICCGYN2091

Discovering Outcomes in Clonal Hematopoiesis: The Clonal Hematopoiesis and Inflammation in VasculaturE (CHIVE) Registry and Biorepository

Hematologic

Disease Sites: Hematologic

Phase: N/A

Investigator: Bick, Alexander

NCTID:

Protocol No: VICCHEM20123

Impact of DHT on Swallowing Physiology in HNCa Patients

Head/Neck

Disease Sites: Head/Neck

Phase: N/A

Investigator: Topf, Michael

NCTID:

Protocol No: VICCHN2102

Liquid Biopsy of The Lung to Profile Lung Cancer

Lung

Disease Sites: Lung

Phase: N/A

Investigator: Maldonado, Fabien

NCTID:

Protocol No: VICCTHO2107

Blood based biomarkers for minimal residual disease detection in Pediatric Sarcomas

Multiple Cancer Types

Disease Sites: Pediatrics, Sarcoma

Phase: N/A

Investigator: Borinstein, Scott

NCTID:

Protocol No: VICCPED2160